NCT00111917View on ClinicalTrials.gov

Beryllium Infliximab Study: Clinical Interventional Trial

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
BerylliosisBeryllium Disease
Interventions
DRUG

Infliximab

anti-TNF

OTHER

Placebo

Placebo infusion

Trial Locations (1)

80401

National Jewish Health, Denver

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Maier, Lisa, M.D.

INDIV

NCT00111917 - Beryllium Infliximab Study: Clinical Interventional Trial | Biotech Hunter | Biotech Hunter